Giselle Lander, O.D.
Optometrist · Lyndhurst, OH
Giselle Lander, O.D. is an optometrist with a practice address in Lyndhurst, Ohio, and NPI 1700050960, issued on Apr 18, 2008. Check the license (Ohio 3717, as entered in NPPES) with the Ohio board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Giselle Lander
- Credential
- O.D.
- Primary taxonomy
- Optometrist 152W00000X
- License number
- 3717 OH
Self-reported in NPPES; status is on the state search - Practice location
- 5035 Mayfield RD, Lyndhurst, OH 44124
- Phone
- (216) 291-2020
- Enumerated
- Apr 18, 2008
- Entity
- Type 1 · individual
Also registered at 5035 Mayfield RD
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Karen Bird, MA OTRLOccupational Therapist1710171152
- James Cermak, D.D.SGeneral Practice Dentistry1093928251
- Kenneth Gerstenhaber, PH.DCognitive & Behavioral Psychologist1245292127
- Robert Goldenberg, D.D.S.Dentist1982794251
- Rodney Green, M.D.Specialist1831280213
- Fredrick Rzepka, D.D.S.Dentist1730520578
Verify Giselle Lander in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Ohio board licenses this profession
Search for license 3717Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
32% more Medicare Part D claims than the average optometrist in 2024
367 Medicare Part D claims for 108 beneficiaries, against an average of 279 among the 32,314 providers of this specialty who prescribed in Part D. Brand-name drugs were 27% of claims.
Most prescribed
- Latanoprost203 claims
- Timolol Maleate49 claims
- Erythromycin17 claims
- Brimonidine Tartrate16 claims
- Dorzolamide-Timolol11 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Optometrist providers in Ohio
There are 2,379 optometrist records in Ohio.
Other optometrist records in Ohio
- Saif AbdulameerBlue Ash, OH1063368496
- Nicole Abrashoff, O.D.Chillicothe, OH1588772933
- Thomas Abruzzi, O.D.Warren, OH1588669790
- Laird Ackerson, O.D.Hilliard, OH1609880624
- Kaitlin Ackinclose, ODCincinnati, OH1669231262
- Cheryl Adams, O.D.Cincinnati, OH1356361570
- Stephany Aeling, ODChillicothe, OH1689508269
- Cindy Ahern, ODSpringfield, OH1710040704
- Betsy Ahlquist, O.D.Canfield, OH1578540092
- Jeffrey Ahrns, O.D.Sidney, OH1659334704
Common questions
What is Giselle Lander, O.D.'s NPI number?
Giselle Lander, O.D.'s National Provider Identifier (NPI) is 1700050960, issued on Apr 18, 2008. An NPI identifies a provider in billing; it is not a license.
Where is Giselle Lander, O.D. located?
The NPPES record lists a practice address at 5035 Mayfield RD, Lyndhurst, OH, 44124. Phone: (216) 291-2020. Providers update this record themselves, so call before visiting.
How can I verify Giselle Lander, O.D.'s license?
NPPES lists Ohio license number 3717, as entered by the provider. Search the Ohio board that licenses this profession; the NPPES record confirms identity only.
How much does Giselle Lander, O.D. prescribe under Medicare Part D?
In 2024, Giselle Lander, O.D. had 367 Medicare Part D claims for 108 beneficiaries; the average among optometrist prescribers was 279. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.